STE logo

STERIS plc Stock Price

NYSE:STE Community·US$23.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

STE Share Price Performance

US$242.50
11.48 (4.97%)
11.0% undervalued intrinsic discount
US$272.38
Fair Value
US$242.50
11.48 (4.97%)
11.0% undervalued intrinsic discount
US$272.38
Fair Value
Price US$242.50
AnalystConsensusTarget US$272.38

STE Community Narratives

AnalystConsensusTarget·Updated
Fair Value US$272.38 11.0% undervalued intrinsic discount

Healthcare Demand And Facility Expansion Will Create Value

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative

Recent STE News & Updates

Calculating The Fair Value Of STERIS plc (NYSE:STE)

Aug 28
Calculating The Fair Value Of STERIS plc (NYSE:STE)

Steris: Marginal Gains Capitalized At Higher Rates, Reiterate Buy

Aug 17

STERIS (NYSE:STE) Is Paying Out A Larger Dividend Than Last Year

Aug 07
STERIS (NYSE:STE) Is Paying Out A Larger Dividend Than Last Year

Is There Now An Opportunity In STERIS plc (NYSE:STE)?

Jul 06
Is There Now An Opportunity In STERIS plc (NYSE:STE)?

STERIS plc Key Details

US$5.6b

Revenue

US$3.1b

Cost of Revenue

US$2.5b

Gross Profit

US$1.8b

Other Expenses

US$647.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
6.58
Gross Margin
44.38%
Net Profit Margin
11.63%
Debt/Equity Ratio
27.3%

STERIS plc Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet with proven track record and pays a dividend.

0 Risks
2 Rewards

About STE

Founded
1985
Employees
17787
CEO
Daniel Carestio
WebsiteView website
www.steris.com

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 1.2%
  • 3 Months: 7.7%
  • 1 Year: 17.9%
  • Year to Date: 14.9%
The market is up 1.2% over the last week, with the Information Technology sector leading the way, up 2.4%. In the last year, the market has climbed 18%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›